@article{JTD12088,
author = {Natalie A. Lockney and Abraham J. Wu},
title = {Alectinib for the management of ALK-positive non-small cell lung cancer brain metastases},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {2},
year = {2017},
keywords = {},
abstract = {Anaplastic lymphoma kinase (ALK) rearrangements were first identified as an oncogenic driver in non-small cell lung cancers (NSCLC) in 2007, specifically the gene re-arrangement between ALK and echinoderm microtubule-associated protein like 4 (EML4) (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/12088}
}